Treatment of posthepatitic cirrhosis by Fuzheng Huayu Tablet (扶正化瘀片) for reinforcing qi and resolving stasis
- 2 April 2013
- journal article
- research article
- Published by Springer Nature in Chinese Journal of Integrative Medicine
- Vol. 19 (4) , 289-296
Abstract
To investigate the efficacy and safety of the Fuzheng Huayu Tablet (扶正化瘀片, FZHYT), which is used to reinforce qi and resolve stasis in patients with posthepatitic cirrhosis (PHC).Keywords
This publication has 18 references indexed in Scilit:
- Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosisGut, 2011
- TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical updateGut, 2010
- Immunologic Characterization of Posthepatitis Cirrhosis Caused by HBV and HCV InfectionJournal of Biomedicine and Biotechnology, 2010
- Noninvasive markers to diagnose cirrhosis in patients with HBeAg positive chronic hepatitis: Do new biomarkers improve the accuracy?Clinical Biochemistry, 2010
- Therapeutic effect of traditional Chinese medicine on coagulation disorder and accompanying intractable jaundice in hepatitis B virus-related liver cirrhosis patientsWorld Journal of Gastroenterology, 2008
- Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluationLiver International, 2007
- Chronic hepatitis BHepatology, 2007
- Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseasesHepatology, 2006
- HEPATIC FIBROSIS: Molecular Mechanisms and Drug TargetsAnnual Review of Pharmacology and Toxicology, 2005
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001